Hemic and Lymphatic Diseases

593 trials 238 recruiting

Filter these 593 trials by phase, country and sponsor.

Open in Search →

A Randomized, Open-labelled, Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard… Recruiting

2025-521634-29-00 Acute Myeloid Leukemia 5 2026-03-02
A Phase 1/2 Open Label Cohort Comparative Study Evaluating the Efficacy and the safety of Gene Therapy of the Sickle Cell Disease by Transpl… Recruiting

2025-521257-17-00 SCD severe patients 7 2026-02-25
Long-Term Follow-up of AvenCell-Sponsored CAR-T Cell Clinical Trials Recruiting

2025-521717-67-00 Acute myeloid leukemia 3 2026-01-29
Safety and Feasibility of a Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning before Allogeneic Stem Cell Transplantatio… Recruiting

2025-521372-62-00 Acute Myeloid Leukemia (AML), Myleodyplastic Neoplasm/A 4 2026-01-29
FILOWM4-WaZaBi: "Open label phase 2 study evaluating the efficacy and tolerance of a zanubrutinib and BGB-11417 combination in patients prev… Recruiting

2023-505781-28-00 Patients with Waldenstrom macroglobulinemia and have re 4 2026-01-20
A trial to learn how safe AZD4512 is and how it works in the bodies of people with B-cell acute lymphoblastic leukemia (B-ALL) Recruiting

2025-522372-93-00 B-cell acute lymphoblastic leukemia (B-ALL) 7 2026-01-13
GRAALL 2024 - A 3-cohort Randomized Study evaluating the role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Tran… Recruiting

2024-511437-35-00 Patients aged 18-65 years old with newly diagnosed prev 10 2026-01-05
A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Recruiting

2024-519745-30-01 Immune Thrombocytopenia (ITP) 9 2025-12-19
A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia Recruiting

2025-521692-31-00 Chronic Primary Immune Thrombocytopenia 5 2025-12-19
A trial to learn how safe AZD4512 is with and without other cancer drugs and how it works in the bodies of people with B-cell non-Hodgkin ly… Recruiting

2025-522371-29-00 Non-Hodgkin lymphoma (NHL) 7 2025-12-19
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residua… Recruiting

2024-512503-39-00 Arm A (AML): Newly diagnosed de novo Acute myeloid leuk 6 2025-12-19
A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol … Recruiting

2025-522004-24-00 iron deficient 11 2025-12-11
Darbepoetin in patients candidates for liver transplant: randomized clinical trial Recruiting

2025-521701-41-00 hepatic trasplant 6 2025-11-25
Safety and Efficacy of Tarperprumig in Adult Participants with ANCA-Associated Vasculitis Recruiting

2025-521706-17-00 Anti-neutrophil cytoplasmic antibody (ANCA)-associated 4 2025-11-25
A Study to Evaluate the Efficacy and Safety of Mezagitamab Subcutaneous Injection Compared With Placebo in Adults With Chronic Immune Thromb… Recruiting

2024-514401-54-00 Chronic Primary Immune Thrombocytopenia 5 2025-11-13
REGN7508 versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults. Recruiting

2025-520478-20-00 Thromboembolic disease 5 2025-11-05
A trial to determine the dose, and evaluate the safety and pharmacokinetics of lutetium Lu 177 edotreotide in children with somatostatin rec… Recruiting

2024-512831-66-00 Pediatric participants aged two to less than 18 years o 3 2025-10-24
Study of IADADEMSTAT for the Treatment of Sickle Cell Disease. Recruiting

2025-521838-29-00 Sickle Cell Disease 3 2025-10-16
A trial aiming to investigate the safety and efficacy of a new drug in patients with primary immune thrombocytopenia previously treated with… Recruiting

2023-509131-12-01 Primary Immune Thrombocytopenia 4 2025-09-30
A phase 2 study of the effectiveness of golcadomide (CC-99282) for patients with large B-cell lymphoma in the brain Recruiting

2024-517051-12-00 Relapsed primary large B-cel lymphoma of the central ne 4 2025-09-16
Study to evaluate the efficacy and safety of enoxaparin in children with slow-flow vascular problems undergoing interventional procedures Recruiting

2025-521196-32-00 Venous malformation or low-flow venous/lymphatic malfor 5 2025-09-12
A phase III placebo-controlled efficacy and safety study of mocravimod as an adjunctive and maintenance treatment in AML patients undergoing… Recruiting

2024-512752-38-00 Adjunctive and maintenance treatment to HCT 5 2025-09-09
Phase I/IIa clinical trial with dose escalation to evaluate safety and efficacy of the infusion of CART84 in relapsed/refractory (R/R) acute… Recruiting

2024-519966-31-00 Relapsed/refractory Acute Lymphoblastic T Leukemia (T-A 7 2025-09-08
A study to evaluate acalabrutinib, in combination with the R-CHOP standard of care, for previously untreated mantle cell lymphoma in Spain. Recruiting

2025-521152-34-00 mantle cell lymphoma (MCL) 4 2025-09-04